Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2020 Aug 12;39:155. doi: 10.1186/s13046-020-01656-1

Correction to: LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway

Yanxia Huang 1, Jing Zhang 1,, Lidan Hou 2, Ge Wang 1, Hui Liu 1, Rui Zhang 1, Xiaoyu Chen 1, Jinshui Zhu 1,
PMCID: PMC7422566  PMID: 32787877

Correction to: J Exp Clin Cancer Res 36, 194 (2017)

https://doi.org/10.1186/s13046-017-0666-2

Following publication of the original article [1], the authors identified an error in Fig. 5; specifically the HGC-27 cell line in figure 5A. The correct figure is given below.

Fig. 5.

Fig. 5

Knockdown of AK023391 inhibited migration and invasion of gastric cancer (GC) cells. a-b Cell migration abilities were respectively determined by the wound-healing assay and Transwell migration assay in si-AK023391-transfected HGC 27, AGS, and SGC-7901 cells. c The cell invasive potential was assessed by the Transwell invasion assay in si-AK023391-transfected HGC 27, AGS, and SGC-7901 cells. **P < 0.01

Contributor Information

Jing Zhang, Email: jing5522724@vip.163.com.

Jinshui Zhu, Email: zhujs1803@163.com.

Reference

  • 1.Huang, et al. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway. J Exp Clin Cancer Res. 2017;36:194. doi: 10.1186/s13046-017-0666-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES